AGX vs PATH · P/E 31, rev $874.2M vs P/E 19, rev $1.61B
Argan Inc (AGX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Argan Inc (AGX) is a engineering & construction company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AGX revenue for 2025-01-31 was $874.2M. Net income was $85.5M. Revenue was up 52.5% from 2024-01-31 to 2025-01-31. AGX currently screens at market cap $3.00B and trailing P/E 30.7.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AGX currently screens at market cap $3.00B and trailing P/E 30.7. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AGX and PATH stock pages for the full models.
Not investment advice.